Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

HIV therapy success rates similar in developing and developed world, study shows

01.08.2005


A new study from the University of Alberta reveals that people with HIV in developing countries do just as well on antiretroviral therapy (ART) programs as do people with HIV on ART programs in developed countries. It also shows that people with HIV who are given free ART drugs will do "significantly" better at fighting the disease compared to those who must pay for the drugs.



"ART programs are complex therapeutic regimens that require patients to take a minimum of three pills a day for the rest of their lives," said Dr. Karen Doucette, a professor in the U of A Division of Infectious Diseases. "It’s often difficult for people in North America to maintain the regimens, so some critics believe these programs can’t work in resource poor settings, where patients don’t have the support--the pharmacists, the social workers, and the physicians, for example--that we have."

However, after reviewing more than 100 research papers on the topic, Doucette and her colleagues concluded ART programs have the same efficacy rates in both developed and non-developed countries. The general success rate in keeping the virus suppressed after being on the program for 12 to 18 months is about 60 per cent. The results are published this month in the journal Clinical Infectious Diseases.


Doucette said she was not surprised with the results, except for the fact that people in developing countries who received free ART drugs did so much better--30 per cent higher rates of success--than people who had to pay for their drugs.

"Although this intuitively makes sense, it was a satisfying surprise to be able to demonstrate the impact of payment for ART on its success. This has important potential implications for ART program development, which is ongoing in many resource-poor settings around the world," Doucette said.

According to the latest numbers from the UN, about 40 million people currently have HIV. The vast majority of these people live in developing countries, with almost 75 per cent living in Sub-Saharan Africa. The UN’s goal is to provide at least 3 million people living with HIV/AIDS in low- and middle-income countries with ART by the end of 2005.

The number of people receiving ART has been increasing in every region in the world, with Sub-Saharan Africa doubling the number of people on ART to 500,000 in the past six months. As of June 2005, about 1 million people are on ART. Doucette believes these recent results are encouraging, but she says there must be ongoing political, financial and technical support to keep the trend going.

"Our study shows that there’s no reason why people in Africa and other resource-poor settings won’t follow ART regimens if they can access the treatments. We just have to make sure that everyone knows this and the support for these programs are strengthened over time," Doucette said.

Ryan Smith | EurekAlert!
Further information:
http://www.ualberta.ca

More articles from Studies and Analyses:

nachricht WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf

nachricht First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Designer cells: artificial enzyme can activate a gene switch

22.05.2018 | Life Sciences

PR of MCC: Carbon removal from atmosphere unavoidable for 1.5 degree target

22.05.2018 | Earth Sciences

Achema 2018: New camera system monitors distillation and helps save energy

22.05.2018 | Trade Fair News

VideoLinks
Science & Research
Overview of more VideoLinks >>>